The global Helicobacter Pylori Diagnostics Market is witnessing steady growth due to the increasing prevalence of gastrointestinal disorders, rising awareness of early disease detection, and growing adoption of advanced diagnostic technologies. Helicobacter pylori infection is a major cause of chronic gastritis, peptic ulcers, and gastric cancer, making accurate and timely diagnosis essential. Increasing investments in molecular diagnostics, non-invasive testing methods, and laboratory automation are further driving market expansion.

According to Fortune Business Insights, the global helicobacter pylori diagnostics market was valued at USD 750.26 million in 2025 and is projected to grow from USD 795.04 million in 2026 to USD 1,264.18 million by 2034, exhibiting a CAGR of 5.97% during the forecast period.  ****

Why is the Helicobacter Pylori Diagnostics Market Growing?

The increasing burden of gastrointestinal diseases and growing emphasis on early diagnosis are among the primary factors driving the Helicobacter Pylori Diagnostics Market. Healthcare providers are increasingly adopting rapid, accurate, and non-invasive diagnostic methods to improve patient outcomes and reduce complications associated with H. pylori infections.

The growing adoption of molecular diagnostics, PCR-based testing, stool antigen tests, and urea breath tests is further accelerating market growth. Rising awareness regarding antibiotic resistance and personalized treatment approaches is also encouraging the use of advanced diagnostic solutions.

Helicobacter pylori diagnostic solutions are widely used for:

• Hospital laboratories
• Diagnostic laboratories
• Gastroenterology clinics
• Point-of-care testing
• Preventive health screening
• Gastric cancer risk assessment
• Infection monitoring
• Clinical research

Growing investments in precision diagnostics and laboratory modernization continue to create significant opportunities for market participants.

Key Market Trends Shaping Industry Growth

Rising Adoption of Non-Invasive Diagnostic Tests

Healthcare providers are increasingly preferring stool antigen tests and urea breath tests due to their high accuracy, patient convenience, and reduced need for invasive endoscopic procedures.

Growing Integration of Molecular Diagnostics

PCR-based assays and molecular diagnostic platforms are gaining popularity because they enable rapid detection of Helicobacter pylori and identification of antibiotic-resistant strains, supporting personalized treatment strategies.